Comparative efficacy and safety of targeted disease-modifying therapies in adults with primary IgA…

Comparative Efficacy and Safety of Systemic Immunomodulatory Therapies for Non‐Infectious Uveitis: A Systematic Review With Pairwise and Network Meta‐Analyses
Kai‐Yang Chen, Hoi‐Chun Chan, Chi‐Ming Chan
Pharmacotherapy13 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
Comparative efficacy of gut microbiota-targeted therapies for motor and non-motor symptoms in Parkinson's disease: a systematic review and network meta-analysis
Xiaoyuan Yang, Yuanping Li, Qinghong Hu +3
Frontiers in Microbiology26 Oct 2026Peer-reviewedCC BY 4.0Full textNeurologyCrossrefDOAJ
Disease-Targeted Therapies and eGFR Slope over 2 Years in IgA Nephropathy: A Systematic Review and Network Meta-Analysis
Y. Tongu, Y. Morita, N. Omizo +1
medRxiv29 Oct 2026PreprintCC BYFull textGeneral medicinemedRxiv
Efficacy of combined therapies on degenerative joint disease of the temporomandibular joint: A systematic review and meta-analysis
Rodrigo Sousa Uva, Eduardo Januzzi, Miguel De Pedro +1
Osteoarthritis and cartilage open17 Oct 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Efficacy, safety, and strategy-modifying factors of pulsed field ablation for persistent and long-standing persistent atrial fibrillation: a systematic review and meta-analysis.
Yuanlin Zhou, Jianhua Xie, Mingliang Fang +3
Frontiers in cardiovascular medicine5 Oct 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMCCrossref

Cite

BibTeX

@misc{liu2026comparative,
  title = {{Comparative efficacy and safety of targeted disease-modifying therapies in adults with primary IgA nephropathy: a systematic review and network meta-analysis}},
  author = {Z. Liu and Y. Wang and M. Zhang and M. Sanchez and Y. Fu and H. Sun and l. Sun},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.25.26366409},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.25.26366409v1},
}

RIS

TY  - UNPB
TI  - Comparative efficacy and safety of targeted disease-modifying therapies in adults with primary IgA nephropathy: a systematic review and network meta-analysis
AU  - Z. Liu
AU  - Y. Wang
AU  - M. Zhang
AU  - M. Sanchez
AU  - Y. Fu
AU  - H. Sun
AU  - l. Sun
PY  - 2026
DA  - 2026/10/25
PB  - medRxiv
DO  - 10.64898/2026.10.25.26366409
UR  - https://www.medrxiv.org/content/10.64898/2026.10.25.26366409v1
ER  -

Related

Cite